Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oropharyngeal Care in Preventing VAP in Preterm Neonates
NCT07482007Completed
- Sponsor
- Tanta University
- Start
- Apr 2024
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of colostrum, chlorhexidine + cymenol gel and sodium bicarbonate in ventilator-associated pneumonia (VAP) (4 arms), sponsored by Tanta University. Primary endpoint: Incidence of Ventilator-Associated Pneumonia at 28 days. Started Apr 2024; status: completed.
02
Drugs
colostrumchlorhexidine + cymenol gelsodium bicarbonate
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07482007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07482007.